INVESTIGADORES
MALVICINI Mariana
artículos
MARIANA MALVICINI; MAYSA SILVEIRA VILBERT; JOSE NICOLAS MINATTA; VALERIA COLOMO COSTAS; MANGLIO RIZZO
Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features
CURRENT TREATMENT OPTIONS IN ONCOLOGY; Lugar: Berlin; Año: 2023
GISELA WEIZ; MOLEJON MARIA INES; MARIANA MALVICINI; CAECILIA SUKOWATI; CLAUDIO TIRIBELLI; GUILLERMO MAZZOLINI; JAVIER BRECCIA
Glycosylated 4-methylumbelliferone as a targeted therapy for hepatocellular carcinoma
LIVER INTERNATIONAL; Lugar: Londres; Año: 2022
GAYET PREISS, FERNANDO; PICCIONI, FLAVIA; FUSCO, MARIEL; DÍAZ GUTIERREZ, MARCO AURELIO; RIBATTO, PAMELA; BAYO, JUAN; RIZZO, MANGLIO; MALVICINI, MARIANA
La modulación de la expresión de ácido hialurónico reduce la resistencia a la quimioterapia de células iniciadoras de tumor en cáncer de pulmón experimental
Oncología Clínica; Año: 2022 vol. 27
RODRÍGUEZ, MARCELO M.; ONORATO, AGOSTINA; CANTERO, MARÍA JOSÉ; DOMÍNGUEZ, LUCIANA; BAYO, JUAN; FIORE, ESTEBAN; GARCÍA, MARIANA; ATORRASAGASTI, CATALINA; CANBAY, ALI; MALVICINI, MARIANA*; MAZZOLINI, GUILLERMO D. *EQUAL CONTRIBUTION
4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
Scientific Reports; Año: 2021 vol. 11
GUILLERMO MAZZOLINI; ALEXIS IRACHETA; MARIANA MALVICINI; JUAN BAYO
Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?
Clinical Liver Disease; Año: 2020
FIORE, ESTEBAN; DOMÍNGUEZ, LUCIANA M.; BAYO, JUAN; MALVICINI, MARIANA; ATORRASAGASTI, CATALINA; RODRIGUEZ, MARCELO; CANTERO, MARÍA JOSÉ; GARCÍA, MARIANA; YANNARELLI, GUSTAVO; MAZZOLINI, GUILLERMO
Human umbilical cord perivascular cells-derived extracellular vesicles mediate the transfer of IGF-I to the liver and ameliorate hepatic fibrogenesis in mice
GENE THERAPY; Año: 2020 vol. 27 p. 62 - 73
BAYO, JUAN; FIORE, ESTEBAN J.; DOMINGUEZ, LUCIANA MARÍA; CANTERO, MARÍA JOSE; CIARLANTINI, MATIAS S.; MALVICINI, MARIANA; ATORRASAGASTI, CATALINA; GARCIA, MARIANA GABRIELA; ROSSI, MARIO; CAVASOTTO, CLAUDIO; MARTINEZ, ELISABETH; COMIN, JULIETA; MAZZOLINI, GUILLERMO D.
Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma
GUT - AN INTERNATIONAL JOURNAL OF GASTROENTEOROLOGY AND HEPATOLOGY; Año: 2020
BAYO, JUAN; FIORE, ESTEBAN J.; DOMINGUEZ, LUCIANA M.; REAL, ALEJANDRINA; MALVICINI, MARIANA; RIZZO, MANGLIO; ATORRASAGASTI, CATALINA; GARCÍA, MARIANA G.; ARGEMI, JOSEPMARIA; MARTINEZ, ELISABETH D.; MAZZOLINI, GUILLERMO D.
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
JOURNAL OF HEPATOLOGY; Lugar: Amsterdam; Año: 2019
ATORRASAGASTI, CATALINA; ONORATO, AGOSTINA; GIMENO, MARÍA L.; ANDREONE, LUZ; GARCIA, MARIANA; MALVICINI, MARIANA; FIORE, ESTEBAN; BAYO, JUAN; PERONE, MARCELO J.; MAZZOLINI, GUILLERMO D.
SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice
CLINICAL SCIENCE (LONDON, ENGLAND : 1979); Año: 2019 vol. 133 p. 351 - 365
GUILLERMO MAZZOLINI; MARIANA MALVICINI
Immunostimulatory monoclonal antibodies for hepatocellular carcinoma therapy. Trends and perspectives.
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2018
MALVICINI, MARIANA; GUTIERREZ-MORAGA, ANA; RODRIGUEZ, MARCELO M.; GOMEZ-BUSTILLO, SOFIA; SALAZAR, LORENA; SUNKEL, CARLOS; NOZAL, LEONOR; SALGADO, ANTONIO; HIDALGO, MANUEL; LOPEZ-CASAS, PEDRO P.; NOVELLA, JOSE LUIS; VAQUERO, JUAN JOSE; ALVAREZ-BUILLA, JULIO; MORA, ADDA; GIDEKEL, MANUEL; MAZZOLINI, GUILLERMO
"A tricin derivative from Deschampsia antarctica Desv. inhibits colorectal carcinoma growth and liver metastasis through the induction of a specific immune response"
MOLECULAR CANCER THERAPEUTICS; Año: 2018
RODRÍGUEZ, MARCELO M.; FIORE, ESTEBAN; BAYO, JUAN; ATORRASAGASTI, CATALINA; GARCÍA, MARIANA; ONORATO, AGOSTINA; DOMÍNGUEZ, LUCIANA; MALVICINI, MARIANA*; MAZZOLINI, GUILLERMO* (EQUAL CONTRIBUTION)
4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12
MOLECULAR THERAPY (PRINT); Año: 2018 vol. 26 p. 2738 - 2750
BAYO J; REAL A; FIORE E; MALVICINI M; SGANGA L; BOLONTRADE M; ANDREANI O; BIZAMA C; FRESNO C; PODHAJCER O; FERNANDEZ E; GIDEKEL M; MAZZOLINI G; GARCIA MG
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness
Oncotarget; Año: 2016
PEIXOTO E; ATORRASAGASTI C; MALVICINI M; FIORE E ; RODRIGUEZ M; GARCIA M; FINOCCHIETO P; PODEROSO JJ; CORRALES F; MAZZOLINI G
SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response.
Oncotarget; Lugar: Albany, N.Y.; Año: 2016
ESTEBAN FIORE; MARIANA MALVICINI; JUAN BAYO; ESTANISLAO PEIXOTO; CATALINA ATORRASAGASTI; ROMINA SIERRA; MARCELO MAXIMILIANO RODRIGUEZ; SOFIA GOMEZ BUSTILLO; MARIANA GARCIA; JORGE AQUINO; GUILLERMO MAZZOLINI
Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells.
Stem Cell Res Ther; Año: 2016
FIORE, E; BAYO J; GARCIA M; MALVICINI M; LLOYD, R; PICCIONI, F; RIZZO, M; PEIXOTO, E; SOLA MB; ATORRASAGASTI C; ALANIZ L; CAMILLETTI MA; ENGUITA, M; PRIETO, J; AQUINO J; MAZZOLINI G
Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice
STEM CELLS AND DEVELOPMENT; Lugar: New York; Año: 2015
PICCIONI F; FIORE E; BAYO J; ATORRASAGASTI, C; PEIXOTO, E; MALVICINI, M; TIRADO-GONZALEZ, I
4-methylumbelliferone inhibits hepatocellular carcinoma growths by decreasing IL-6 production and angiogenesis.
GLYCOBIOLOGY; Lugar: Oxford; Año: 2015
MARIANA MALVICINI; ESTEBAN FIORE; VALENTINA GHIACCIO; FLAVIA PICCIONI; MIGUEL RIZZO; LUCILA OLMEDO BONADEO; MARIANA GARCIA; MARCELO MAXIMILIANO RODRIGUEZ; JUAN BAYO; ESTANISLAO PEIXOTO; CATALINA ATORRASAGASTI; LAURA ALANIZ; JORGE AQUINO; PABLO MATAR; GUILLERMO MAZZOLINI
Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.
MOLECULAR THERAPY (PRINT); Lugar: San Diego; Año: 2015
RIZZO M; BAYO. J; PICCIONI F; MALVICINI M; FIORE E; PEIXOTO E; GARCIA M; AQUINO J; GONZALEZ CAMPAÑA A; PODESTÁ G; TERRES M; ANDREANI O; ALANIZ L; MAZZOLINI G
Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction
PLOS ONE; Lugar: San Francisco; Año: 2014
MALVICINI M; AQUINO J; MAZZOLINI G
Combined Therapy for Gastrointestinal Carcinomas: Exploiting Synergies Between Gene Therapy and Classical Chemo-Radiotherapy
CURRENT GENE THERAPY; Lugar: Oak Park; Año: 2014
BAYO. J; FIORE. EF; AQUINO, JB; MALVICINI M; RIZZO, M; PEIXOTO E; ALANIZ L; PICCIONI F; BOLONTRADE M
Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.
BioMed research international; Año: 2014
BAYO J; AQUINO J; MALVICINI M; RIZZO M; PEIXOTO E; ANDREANI O; ALANIZ L; PICCIONI F; BOLONTRADE M; PODHAJCER O; GARCIA M; MAZZOLINI G
Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma.
PLOS ONE; Lugar: San Francisco; Año: 2014 vol. 9 p. 95171 - 95181
ATORRASAGASTI, M.1; ; PEIXOTO, E.; AQUINO, J.; KIPPES. N; MALVICINI M; ALANIZ. L; GARCIA. M; PICCIONI. F; FIORE. EF; BAYO. J; BATALLER R,; GURUCEAGA E,; CORRALES F,; PODHAJCER O,; MAZZOLINI G.
Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.
PLOS ONE; Lugar: San Francisco; Año: 2013 vol. 8 p. 54962 - 54963
MARIANA MALVICINI, LAURA ALANIZ, JUAN BAYO, MARIANA GARCÍA, FLAVIA PICCIONI,ESTEBAN FIORE, CATALINA ATORRASAGASTI, JORGE B. AQUINO PABLO MATAR AND GUILLERMO MAZZOLINI
Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
OncoImmunology; Lugar: Austin, TX; Año: 2012 p. 1038 - 1047
MARIANA MALVICINI, FLAVIA PICCIONI, JUAN BAYO, ESTEBAN FIORE, CATALINA ATORRASAGASTI, LAURA ALANIZ, MARIANA GARCÍA, JORGE B. AQUINO,PABLO MATAR AND GUILLERMO MAZZOLINI; MANUEL GIDEKEL
Chemoimmunotherapy for advanced gastrointestinal carcinomas A successful combination of gene therapy and cyclophosphamide
OncoImunology; Año: 2012
ATORRASAGASTI C, AQUINO JB, HOFMAN L, ALANIZ L, MALVICINI M, GARCIA M, BENEDETTI L, FRIEDMAN SL, PODHAJCER OL, MAZZOLINI GD
SPARC down-regulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-beta1 and PDGF.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY; Año: 2011 vol. 300 p. 739 - 748
MALVICINI M, INGOLOTTI M, PICCIONI F, GARCIA M, BAYO J, ATORRASAGASTI C, ALANIZ L, AQUINO JB, ESPINOZA JA, GIDEKEL M, SCHAROVSKY OG, MATAR P, MAZZOLINI G. SOURCE
Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12
MOLECULAR ONCOLOGY; Año: 2011 vol. 5 p. 242 - 255
GARCIA MG, BAYO J, BOLONTRADE MF, SGANGA L, MALVICINI M, ALANIZ L, AQUINO JB, FIORE E, RIZZO MM, RODRIGUEZ A, LORENTI A, ANDRIANI O, PODHAJCER O, MAZZOLINI G
Hepatocellular Carcinoma Cells and Their Fibrotic Microenvironment Modulate Bone Marrow-Derived Mesenchymal Stromal Cell Migration in Vitro and in Vivo
MOLECULAR PHARMACOLOGY; Año: 2011 p. 1538 - 1548
ALANIZ L, RIZZO M, GARCIA MG, PICCIONI F, AQUINO JB, MALVICINI M, ATORRASAGASTI C, BAYO J, ECHEVERRIA I, SAROBE P, MAZZOLINI G.
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.
CANCER IMMUNOLOGY IMMUNOTHERAPY; Año: 2011 p. 1 - 13
PICCIONI F, MALVICINI M, GARCIA MG, RODRIGUEZ A, ATORRASAGASTI C, KIPPES N, BUENA IT, RIZZO MM, BAYO J, AQUINO J, VIOLA M, PASSI A, ALANIZ L, MAZZOLINI G.
Antitumor effects of hyaluronic acid inhibitor 4-Methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
GLYCOBIOLOGY; Año: 2011
MALVICINI M, PUCHULO G, MATAR P, MAZZOLINI G.
INMUNOTERAPIA DEL CÁNCER. IMPORTANCIA DE CONTROLAR LA INMUNOSUPRESIÓN.
MEDICINA-BUENOS AIRES; Año: 2010 vol. 70 p. 565 - 570
MARIANA MALVICINI, MIGUEL RIZZO, LAURA ALANIZ, FEDERICO PIÑERO, MARIANA GARCÍA, CATALINA ATORRASAGASTI, JORGE B. AQUINO, VIVIANA ROZADOS,O. GRACIELA SCHAROVSKY,PABLO MATAR, GUILLERMO MAZZOLINI
A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice
CLINICAL CANCER RESEARCH; Año: 2009 vol. 15 p. 7256 - 7265
ALANIZ L, RIZZO M, MALVICINI M, JAUNARENA J, AVELLA D, ATORRASAGASTI C, AQUINO JB, GARCIA M, MATAR P, SILVA M, MAZZOLINI G.
Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response
CANCER LETTERS; Año: 2009 vol. 278 p. 9 - 16
ATORRASAGASTI C, MALVICINI M, AQUINO JB, ALANIZ L, GARCIA M, BOLONTRADE M, RIZZO M, PODHAJCER OL, MAZZOLINI G.
Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2009 vol. 126 p. 2726 - 2740
MATAR P, ALANIZ L, ROZADOS V, AQUINO JB, MALVICINI M, ATORRASAGASTI C,, MAZZOLINI G
IMMUNOTHERAPY FOR LIVER TUMORS: PRESENT STATUS AND FUTURE PROSPECTS.
JOURNAL OF BIOMEDICAL SCIENCE; Año: 2009 p. 16 - 30